Inventor · disambiguated record
Michael J. Dey
Also filed as: DEY MICHAEL · DEY MICHAEL J · DEY MICHAEL JOHN
12 granted patents·5 pending applications·388 citations·filing 1987–2024
92Inventor score
Files withBRITANNIA PHARMACEUTICALS LTD4SYNTEX INC4RADIUS HEALTH INC3DEY MICHAEL J2RHYTHM PHARMACEUTICALS INC2
Top patents by PatentIndex Score
17 records- 0196US7803770B2Method of treating osteoporosis comprising administration of PTHrP analogRADIUS HEALTH INC·Filed 2008·Granted Sep 28, 2010·37 cites·14 claims
- 0293US8748382B2Method of drug delivery for bone anabolic proteinDEY MICHAEL J·Filed 2012·Granted Jun 10, 2014·19 cites·12 claims
- 0390USRE49444EMethod of treating osteoporosis comprising administration of PTHrP analogRADIUS HEALTH INC·Filed 2020·Granted Mar 7, 2023·2 cites·79 claims
- 0489US8148333B2Stable composition comprising a PTHrP analogueDEY MICHAEL J·Filed 2007·Granted Apr 3, 2012·22 cites·13 claims
- 0588US5198226ALong acting nicardipine hydrochloride formulationSYNTEX INC·Filed 1991·Granted Mar 30, 1993·110 cites·10 claims
- 0685US4940556AMethod of preparing long acting formulationSYNTEX INC·Filed 1987·Granted Jul 10, 1990·90 cites·12 claims
- 0781US11026938B2Therapeutical composition containing apomorphine as active ingredientBRITANNIA PHARMACEUTICALS LTD·Filed 2014·Granted Jun 8, 2021·2 cites·20 claims
- 0874US5209933ALong acting calcium channel blocker compositionSYNTEX INC·Filed 1991·Granted May 11, 1993·50 cites·8 claims
- 0974US2025186536A1Sustained release peptide formulationsRHYTHM PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1073US11766431B2Therapeutical composition containing apomorphine as active ingredientBRITANNIA PHARMACEUTICALS LTD·Filed 2021·Granted Sep 26, 2023·0 cites·18 claims
- 1169US5164405ANicardipine pharmaceutical composition for parenteral administrationSYNTEX INC·Filed 1990·Granted Nov 17, 1992·50 cites·9 claims
- 1258US2021169965A1Sustained release peptide formulationsRHYTHM PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 1356US2011092425A1Method of drug delivery for bone anabolic proteinRADIUS HEALTH INC·Filed 2010·Application pending·0 cites
- 1455US2018098981A1Therapeutical composition containing apomorphine as active ingredientBRITANNIA PHARMACEUTICALS LTD·Filed 2017·Application pending·0 cites
- 1551US2016310480A1Therapeutical composition containing apomorphine as active ingredientBRITANNIA PHARMACEUTICALS LTD·Filed 2016·Application pending·0 cites
- 1647US4973591AParenteral formulations of 1-diphenylmethyl-4-((2-(4-methylphenyl)-5-methyl-1H-imidazol-4-yl)methyl)piperazineSYNTEX PHARMA LTD·Filed 1988·Granted Nov 27, 1990·4 cites·17 claims
- 1730US5063220AParenteral formulations of 1-diphenylmethyl-4-((2-(4-methylphenyl)-5-methyl-1H-imidazol-4-yl)methyl)piperazineSYNTEX PHARMA LTD·Filed 1990·Granted Nov 5, 1991·2 cites·9 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →